Aripiprazole versus ziprasidone for schizophrenia

Hong Ling Yang*, Jiangang ZHENG, Bin Li, Sai Zhao, Wei Zheng

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare the clinical efficacy and safety of aripiprazole versus ziprasidone for the treatment of people with schizophrenia.

Original languageEnglish
Article numberCD012811
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number9
DOIs
Publication statusPublished - 28 Sep 2017

Scopus Subject Areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Aripiprazole versus ziprasidone for schizophrenia'. Together they form a unique fingerprint.

Cite this